Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B trial 9342.
- Citation:
- J Clin Oncol vol 22 (11) 2061-8
- Year:
- 2004
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA03927, CA04457, CA07968, CA12046, CA21060, CA32291, CA33601, CA41287, CA47559, CA47577, CA60138, CA77406, CA77651
- Corr. Author:
- Authors:
- Eric P Winer Donald A Berry Susan Woolf David Duggan Alice Kornblith Lyndsay N Harris Richard A Michaelson Jeffrey A Kirshner Gini F Fleming Michael C Perry Mark L Graham Stewart A Sharp Roger Keresztes I Craig Henderson Clifford Hudis Hyman Muss Larry Norton
- Networks:
- Study
- CALGB-9342
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Antineoplastic Agents, Phytogenic, Breast Neoplasms, Disease-Free Survival, Dose-Response Relationship, Drug, Female, Humans, Logistic Models, Multivariate Analysis, Paclitaxel, Quality of Life, Survival Rate, Treatment Failure, United States